Advertisement

Obesity Surgery

, Volume 19, Issue 12, pp 1678–1684 | Cite as

The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory

  • Antônio Roberto Franchi Teixeira
  • Marta Bellodi-PrivatoEmail author
  • José Barreto Carvalheira
  • Victor Fernando Pilla
  • José Carlos Pareja
  • Luiz Augusto Carneiro D´Albuquerque
Clinical Report

Abstract

Background

Nonalcoholic steatohepatitis (NASH) is a morbid condition highly related to obesity. It is unclear if the macroscopic liver appearance correlates with the histopathologic findings. The goal of this prospective study was to determine the relationship between the intraoperative liver appearance and the histopathologic diagnosis of NASH in morbidly obese subjects undergoing bariatric surgery. We also aimed to determine variables that could predict NASH preoperatively.

Methods

Consecutive 51 subjects undergoing bariatric surgery without evidence of other liver disease underwent intraoperative liver biopsy. An intraoperative liver visual (macroscopic and tactile examination) was recorded. The liver aspect was compared with the liver histologic findings. Histological assessment was categorized into two groups: NASH and non-NASH (including normal histology and simple steatosis). Clinical and biochemical parameters were obtained from the patient databases and were compared between groups to identify preoperatively predictive factors of NASH.

Results

From 51 patients, only one presented totally normal histology. Forty-three (86.2%) presented simple steatosis, and seven (13.7%) were classified as NASH. Clinical parameters were not different between groups. At biochemical analysis, only VLDL cholesterol level was significantly higher in the NASH group (p = 0.037) but yet within the normal range. Association between macroscopic liver appearance and the presence of histological NASH is poor (sensitivity of 14%, specificity of 56%, positive predictive value of 5%, and negative predictive value of 80%).

Conclusions

No predictor of NASH was found. Surgeons’ evaluation could not identify NASH individuals. Routine liver biopsy during bariatric operations is mandatory to differentiate NASH and nonalcoholic fatty liver disease.

Keywords

Liver biopsy Obesity Steatosis Bariatric surgery Nonalcoholic Steatohepatitis (NASH) Predictors of NASH 

References

  1. 1.
    Blackburn GL, Mun EC. Effects of weight loss surgeries on liver disease. Semin Liver Dis. 2004;24:371–9. Review.CrossRefGoogle Scholar
  2. 2.
    Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–5.CrossRefGoogle Scholar
  3. 3.
    Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol. 2006;44:197–208. Review.CrossRefGoogle Scholar
  4. 4.
    Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr. 1992;55:582S–5S.CrossRefGoogle Scholar
  5. 5.
    Dixon JB, Bhathal PS, Hughes NR, et al. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39:1647–54.CrossRefGoogle Scholar
  6. 6.
    Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600–6.CrossRefGoogle Scholar
  7. 7.
    Ong JP, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005;15:310–5.CrossRefGoogle Scholar
  8. 8.
    Stratopoulos C, Papakonstantinou A, Terzis I, et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg. 2005;15:1154–60.CrossRefGoogle Scholar
  9. 9.
    Beymer C, Kowdley KV, Larson A, et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg. 2003;138:1240–4.CrossRefGoogle Scholar
  10. 10.
    Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91–100.CrossRefGoogle Scholar
  11. 11.
    Moretto M, Kupski C, Mottin CC, et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg. 2003;13:622–4.CrossRefGoogle Scholar
  12. 12.
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31. Review.CrossRefGoogle Scholar
  13. 13.
    Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(Suppl 1):S5–10. Review.PubMedGoogle Scholar
  14. 14.
    Dolce CJ, Russo M, Keller JE, et al. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis. 2009;5:323–8.CrossRefGoogle Scholar
  15. 15.
    Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2001;21:27–41. Review.CrossRefGoogle Scholar
  16. 16.
    Furuya CK Jr, de Oliveira CP, de Mello ES, et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol. 2007;22:510–4.CrossRefGoogle Scholar
  17. 17.
    Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343–51.CrossRefGoogle Scholar
  18. 18.
    Sazci A, Akpinar G, Aygun C, et al. Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. Dig Dis Sci. 2008;53:3218–24.CrossRefGoogle Scholar
  19. 19.
    Huang Y, Liu XQ, Rall SC Jr, et al. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem. 1998;273:26388–93.CrossRefGoogle Scholar
  20. 20.
    Wouters K, van Gorp PJ, Bieghs V, et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology. 2008;48:474–86.CrossRefGoogle Scholar
  21. 21.
    Frantzides CT, Carlson MA, Moore RE, et al. Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. J Gastrointest Surg. 2004;8:849–55.CrossRefGoogle Scholar
  22. 22.
    Boza C, Riquelme A, Ibañez L, et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg. 2005;15:1148–53.CrossRefGoogle Scholar
  23. 23.
    Helling TS, Helzberg JH, Nachnani JS, et al. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? Surg Obes Relat Dis. 2008;4:612–7.CrossRefGoogle Scholar
  24. 24.
    Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord. 1998;22:222–6.CrossRefGoogle Scholar
  25. 25.
    Chitturi S, Farrell G, Frost L, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology. 2002;36:403–9.CrossRefGoogle Scholar
  26. 26.
    Geloneze B, Tambascia MA, Pareja JC, et al. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes. Obes Surg. 2001;11:693–8.CrossRefGoogle Scholar
  27. 27.
    Björntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132–43. Review.CrossRefGoogle Scholar
  28. 28.
    Vohl MC, Sladek R, Robitaille J, et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res. 2004;12:1217–22.CrossRefGoogle Scholar
  29. 29.
    Fujioka S, Matsuzawa Y, Tokunaga K, et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36:54–9.CrossRefGoogle Scholar
  30. 30.
    Kanai H, Matsuzawa Y, Kotani K, et al. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension. 1990;16:484–90.CrossRefGoogle Scholar
  31. 31.
    Collins D, Hogan AM, O’Shea D, et al. The omentum: anatomical, metabolic, and surgical aspects. J Gastrointest Surg. 2009;13:1138–46.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Antônio Roberto Franchi Teixeira
    • 1
  • Marta Bellodi-Privato
    • 1
    Email author
  • José Barreto Carvalheira
    • 2
  • Victor Fernando Pilla
    • 3
  • José Carlos Pareja
    • 2
  • Luiz Augusto Carneiro D´Albuquerque
    • 1
  1. 1.Liver Transplantation Division, Department of Gastroenterology, School of MedicineUniversity of São PauloSão PauloBrazil
  2. 2.School of Medical SciencesUniversity of Campinas-UNICAMPSão PauloBrazil
  3. 3.ENDOCAMP- Center of Digestive and Bariatric SurgeryCampinasBrazil

Personalised recommendations